October 10, 2012 — El Camino Hospital announced it is the first facility in the San Francisco Bay Area to adopt Volpara breast density measurement software from Matakina Intl. The hospital’s breast health center is among the latest California breast imaging facilities that have adopted the objective breast density assessment tool designed to improve early detection among women with dense breasts, including Sutter Health Foundation Women’s Center in Santa Rosa and North Valley Breast Clinic in Redding.
“It is critical for physicians and patients to have as many resources available as possible to detect breast cancer, especially among women for whom the traditional mammogram may not be enough,” said Imtiaz Qureshi, M.D., medical director and chief of radiology at El Camino Hospital in Mountain View. “Volpara, when used in concert with advanced imaging technology, can increase the chances for an accurate diagnosis leading to early treatment and a greater possibility for long-term survival.”
Cleared by the U.S. Food and Drug Administration (FDA), HealthCanada, Australia’s Therapeutic Goods Association (TGA) and CE-marked, Volpara is in use at sites across the globe, helping radiologists assess breast density more objectively and helping them better consider who might benefit from additional screening. Volpara automatically generates objective, automatic measurement of volumetric breast density values under the Volpara Density Grade (VDG) – a refined grading system which correlates with the American College of Radiology BIRADS Density Grading Classifications. Volpara is FDA-cleared for all digital mammography units, and integration with other digital mammography systems, CAD systems and mammography reporting system are also under way.
“El Camino Hospital is well known as an early adopter of innovative technology to help them deliver better care to their patients. Coming on the heels of California becoming the fifth state to enact density inform legislation, El Camino continues to demonstrate this leadership with the implementation of the Volpara breast imaging software which provides an accurate, objective breast density measurement designed to improve radiologists’ understanding of breast density and help them in guiding patients to make appropriate screening decisions,” said Ralph Highnam, CEO of Matakina Intnl.
For more information: www.elcaminohospital.org, www.matakina.com
July 29, 2024 
